Krilogy Financial’s Halozyme HALO Stock Holding History

Krilogy Financial’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-300	Closed	-$5K	–	796
2017 Q3	$5K	Hold	300	–	–	﹤0.01%	651
2017 Q2	$4K	Hold	300	–	–	﹤0.01%	610
2017 Q1	$3K	Hold	300	–	–	﹤0.01%	622
2016 Q4	$3K	Hold	300	–	–	﹤0.01%	622
2016 Q3	$4K	Hold	300	–	–	﹤0.01%	615
2016 Q2	$3K	Hold	300	–	–	﹤0.01%	654
2016 Q1	$3K	Hold	300	–	–	﹤0.01%	579
2015 Q4	$5K	Hold	300	–	–	﹤0.01%	316
2015 Q3	$4K	Buy	+300	New	+$6.02K	﹤0.01%	484

Other funds holding HALO

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Krilogy Financial's HALO Position: Q4 2017 in Review

Krilogy Financial sold out of Halozyme (HALO) in Q4 2017, closing a stake of 300 shares — an estimated $5K sold.

Krilogy Financial first reported a position in HALO in Q3 2015 and held it in 9 quarters. The position peaked at $5K in Q3 2017. 198 funds tracked by Wall St. Rank hold HALO as of Q4 2017.

Krilogy Financial reported no remaining Halozyme position as of Q4 2017 after selling out during the quarter.
Krilogy Financial sold 300 Halozyme shares in Q4 2017, an estimated $5K.
Krilogy Financial first reported a position in Halozyme in Q3 2015 and held it in 9 quarters.
Krilogy Financial's Halozyme position peaked at $5K in Q3 2017.
198 funds tracked by Wall St. Rank held Halozyme as of Q4 2017.

Based on Krilogy Financial's 13F filing for Q4 2017, filed 14 Feb 2018.